An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in quality health care accountability and protection, further providing for definitions and providing for utilization management for stage four, advanced metastatic cancer drugs; and making a repeal.
Referred to Banking & Insurance
Email me when HB 2427 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 2427. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill defines "stage four, advanced metastatic cancer" and adds a rule that health insurers cannot force patients to try and fail other treatments before covering a drug that is FDA‑approved for that condition and backed by best clinical practice and peer‑reviewed research. It repeals the 2020 Fair Access to Cancer Treatment Law but leaves its existing contracts and regulations in place. The goal is to improve access to effective therapies for patients with advanced cancer.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 2427
3 free questions a day, no accountHistory
- Removed from table
- Reported as committed
- Laid on the table
- First consideration
- Referred to Insurance
Sponsors
- Perry Warren (D) · sponsor
- Arvind Venkat
- Benjamin Sanchez
- Carol Hill-Evans
- David Delloso
- Ed Neilson
- Greg Vitali
- Kerry Benninghoff
- Tina Pickett
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 2427 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 2427 freeOr ask your AI assistant about HB 2427 directly:
Add to Claude, ChatGPT or Cursor